Alessio Fasano of Massachusetts General Hospital in the U.S. will isolate bacteriophage (viruses that infect bacteria) that specifically kill pathogenic Escherichia coli and Shigella bacteria, which cause environmental enteropathy and other potentially deadly childhood diseases. They will perform a high-throughput screen using a diverse phage library to isolate phage that specifically target the type-III secretion system expressed by enteric pathogens like E. coli. They will also test an alternative approach by constructing phage to carry so-called CRISPR-Cas9 nucleases that they will engineer to target and cleave bacterial type-III secretion system genes. Results from both approaches will be tested for their capacity to selectively kill enteric pathogens and inhibit infection in a human organoid model, which consists of different cell layers to mimic the structure and function of the human gut.

Brian Foy of Colorado State University in the U.S. will use antibodies that bind essential proteins in the mosquito Anopheles in order to block malaria transmission. They have already produced antibodies that bind conserved mosquito antigens such as the glutamate-gated chloride channel and used them to supplement blood meals, which was lethal to feeding mosquitoes. They will test whether cattle injected with these antigens produce the corresponding antibodies that are also lethal to the mosquitoes that feed off them.

Jason Gill of Texas A&M AgriLife Research in the U.S. will develop an animal model for environmental enteropathy, which is a chronic inflammatory condition of the gut prevalent in children from low-income countries, to test new bacteriophage-based treatments. Bacteriophage (phage) are viruses that infect and can kill bacteria, and can therefore be used to treat bacterial diseases. They will develop a chronic disease model by infecting weaned piglets with low doses of enterotoxigenic Escherichia coli, which is likely involved in environmental enteropathy development in humans. They will also search for a combination of different phage types that can infect and destroy this bacterial strain and effectively cure the disease in their animal model.

Margaret McConnell of Harvard University and Mindy Hernandez of Mobiles4All (M4A) in the U.S. will generate rich datasets related to mobile phone use in Africa by providing mobile phones and incentives for users to share data. These datasets are of value to policymakers to promote the use of mobile money. They are collaborating with mobile network operator Vodacom Mozambique, behavioral scientists at Harvard University and developmental experts. They will run a pilot test, offering at-cost smart phones to 5,000 low-income customers in Mozambique, and evaluate the value of offering rewards in exchange for completing phone-based surveys. These surveys will be far quicker and simpler and cost less than traditional population-based surveys. They will combine the survey data with mobile network data, and package the results into a simple dashboard that can inform about mobile money use and how it might be enhanced.